Literature DB >> 26935515

Xerostomia of Various Etiologies: A Review of the Literature.

Marta Tanasiewicz1, Tomasz Hildebrandt2, Izabela Obersztyn1.   

Abstract

This paper presents the etiopathogenesis, symptomatology, evaluation and treatment of mouth dryness. Xerostomia affects 1-29% of the population, mostly women. It is observed in geriatric patients and in individuals using certain medications, those subjected to radiotherapy of the head and neck region or affected with autoimmune conditions. The main signs of xerostomia include the impression of a dry mouth, problems with food ingestion and dryness of the oral mucosa and skin. Evaluation is based on structured interviews (the Fox test) and determinations of unstimulated and stimulated salivary volume. The signs of xerostomia can be attenuated with saliva substitutes, cevimeline or malic acid. Only palliative treatment of this condition is available at present. Untreated xerostomia significantly impairs the quality of life, which can potentially lead to depression.

Entities:  

Mesh:

Year:  2016        PMID: 26935515     DOI: 10.17219/acem/29375

Source DB:  PubMed          Journal:  Adv Clin Exp Med        ISSN: 1899-5276            Impact factor:   1.727


  34 in total

1.  Oral dryness and moisture degree at the lingual but not buccal mucosa predict prognosis in end-of-life cancer patients.

Authors:  Maiko Shimosato; Naoki Sakane
Journal:  Support Care Cancer       Date:  2021-04-14       Impact factor: 3.603

2.  A feasibility and efficacy trial of a hand-held humidification device in patients undergoing radiotherapy for head and neck cancer.

Authors:  Priyanka Ghosh; Ann A Lazar; William R Ryan; Sue S Yom
Journal:  Support Care Cancer       Date:  2017-03-28       Impact factor: 3.603

3.  The relationship between the severity of oral dryness and the use of dry-mouth interventions by various subgroups of dry-mouth patients.

Authors:  Z Assy; H S Brand; C P Bots; F J Bikker
Journal:  Clin Oral Investig       Date:  2022-01-10       Impact factor: 3.573

4.  Temporomandibular Disorders and Oral Features in Idiopathic Inflammatory Myopathies (IIMs) Patients: An Observational Study.

Authors:  Vito Crincoli; Mariangela Cannavale; Angela Pia Cazzolla; Mario Dioguardi; Maria Grazia Piancino; Mariasevera Di Comite
Journal:  Int J Med Sci       Date:  2021-07-05       Impact factor: 3.738

5.  Post-COVID-19 tsunami of periodontal diseases.

Authors:  Adileh Shirmohammadi
Journal:  J Adv Periodontol Implant Dent       Date:  2021-06-09

Review 6.  A Review on the Role of Pilocarpine on the Management of Xerostomia and the Importance of the Topical Administration Systems Development.

Authors:  Afroditi Kapourani; Konstantinos N Kontogiannopoulos; Panagiotis Barmpalexis
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-18

7.  A Possible Novel Protective Effect of Piceatannol against Isoproterenol (ISO)-Induced Histopathological, Histochemical, and Immunohistochemical Changes in Male Wistar Rats.

Authors:  Samar A Alghamdi; Maryam H Mugri; Nahid M H Elamin; Mona Awad Kamil; Hind Osman; Basma G Eid; Rasheed A Shaik; Soad S Shaker; Aziza Alrafiah
Journal:  Curr Issues Mol Biol       Date:  2022-05-27       Impact factor: 2.976

8.  Challenges in Obtaining and Assessing Salivary Cortisol and α-Amylase in an Over 60 Population Undergoing Psychotherapeutic Treatment for Complicated Grief: Lessons Learned.

Authors:  Jesse M Bell; Tina M Mason; Harleah G Buck; Cindy S Tofthagen; Allyson R Duffy; Maureen W Groër; James P McHale; Kevin E Kip
Journal:  Clin Nurs Res       Date:  2020-11-20       Impact factor: 2.075

9.  Interventions for the treatment of xerostomia: A randomized controlled clinical trial.

Authors:  Constanza Marín; Laura Díaz-de-Valdés; Catalina Conejeros; René Martínez; Sven Niklander
Journal:  J Clin Exp Dent       Date:  2021-02-01

Review 10.  Pathogenesis of taste impairment and salivary dysfunction in COVID-19 patients.

Authors:  Yasuo Okada; Ken Yoshimura; Shuji Toya; Makoto Tsuchimochi
Journal:  Jpn Dent Sci Rev       Date:  2021-07-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.